Heartworm disease - Overview, intervention, and industry perspective.

Dirofilaria immitis, also known as heartworm, is a major parasitic threat for dogs and cats around the world. Because of its impact on the health and welfare of companion animals, heartworm disease is of huge veterinary and economic importance especially in North America, Europe, Asia and Australia. Within the animal health market many different heartworm preventive products are available, all of which contain active components of the same drug class, the macrocyclic lactones. In addition to compliance issues, such as under-dosing or irregular treatment intervals, the occurrence of drug-resistant heartworms within the populations in the Mississippi River areas adds to the failure of preventive treatments. The objective of this review is to provide an overview of the disease, summarize the current disease control measures and highlight potential new avenues and best practices for treatment and prevention.

Efficacy of a barrier gel for reducing the development of plaque, calculus, and gingivitis in cats.

This study was performed to assess the field efficacy of a professional and home-care barrier gel against the development of plaque, calculus, gingival bleeding, and gingivitis in client-owned cats over a 56-day period compared with negative controls. In a randomized, negative-controlled, outcome evaluator-blinded, client-owned animal clinical field study, 31 cats were evaluated to assess if the barrier gel dental product was effective in cats. Following an enrollment-qualification assessment and enrollment of each cat, all cats received a professional dental cleaning, including polishing and irrigation. Following cleaning, a post-cleaning assessment was performed by the evaluator. Then, using a pre-developed randomization schedule, cats were assigned to the treated or control group. The professional version of the barrier gel was applied to the treated group on day 0. The negative-control group patients did not receive any applications of the barrier gel following dental cleaning. Treated-group cats were brought back to the clinic for subsequent applications of the home-care version of the barrier gel, applied by a non-blinded trained assistant. The home-care version product applications began on day 14 and then were applied weekly (days, 21, 28, 35, 42, 49 and 56) through day 56. All cats enrolled in the study underwent full oral examinations and assessments by the blinded evaluator on or about their respective days 28 and 56. At these evaluations, the evaluator performed standardized assessments for plaque, calculus, gingivitis, and gingival bleeding. Numeric scores were assigned for each assessment using predetermined target teeth to ensure consistency. Using these assessment scores, statistical analyses were performed to determine the efficacies against plaque and calculus deposition; additionally, measurements of gingivitis and gingival bleeding were assessed. Change in plaque score from baseline, for all teeth assessed (all 4 canine teeth, and all 4 [corrected] premolar teeth), was significantly (P < 0.05) lower for treated cats than for control cats for both left side average and right side average on day 56. No statistical differences were seen for calculus, gingivitis, or gingival bleeding in this study. In cats with a history of developing plaque, application of the barrier gel dental product following dental cleaning reduced plaque deposition (P < 0.05) compared with control cats.

Evaluation of oral administration of firocoxib for the management of musculoskeletal pain and lameness associated with osteoarthritis in horses.

OBJECTIVE: To generate data on the effects of firocoxib administration to horses with osteoarthritis. ANIMALS: Client-owned horses with signs of lameness and joint pain associated with osteoarthritis. PROCEDURES: Firocoxib was administered as an oral paste (0.1 mg/kg, q 24 h) for 14 days. Assessments were performed on day 0 (baseline) and days 7 and 14. RESULTS: 390 of 429 horses from 80 sites in 25 states met the criteria for analysis. Quarter Horse and Thoroughbred were the 2 most commonly represented breeds, comprising half of the study population. Signs of musculoskeletal pain or lameness attributed to osteoarthritis were diagnosed in a single joint in 197 (197/390 [50.5%]) horses and in multiple joints in 193 (193/390 [49.5%]) horses. In those with involvement of a single joint, the tarsus was the most frequently affected joint (79/197 [40.1 %]). Among the 390 horses with complete lameness data, improvement was reported in approximately 80% by day 14. Investigators rated 307 (78.7%) horses as improved, whereas owners or handlers rated 316 (81.0%) horses as improved at the termination of the study. Horses treated with firocoxib paste had significant improvement in lameness scores from baseline values. Improvement was most rapid within the first 7 days after starting treatment and continued, albeit at a slower rate, through treatment day 14. CONCLUSIONS AND CLINICAL RELEVANCE: Firocoxib significantly improved lameness scores throughout the 14-day period with few adverse effects. Firocoxib can be a safe cyclooxygenase-2-specific NSAID for the treatment of musculoskeletal pain and lameness associated with osteoarthritis.

Gastric ulcer development in horses in a simulated show or training environment.

OBJECTIVE: To determine whether conditions representing activities that are typical in the recreational use of horses, including transport to and from show grounds, stall confinement in unfamiliar surroundings, and light exercise, are associated with increased incidence of gastric ulcers in horses. DESIGN: Randomized controlled study. ANIMALS: 20 client-owned horses. PROCEDURE: Horses had no gastric ulcers as determined by endoscopic examination on study day -1. Ten control horses were maintained on-site with no changes in management variables. Ten horses were transported via trailer for 4 hours on day 0 to another site, placed in individual stalls, fed twice daily, and exercised twice daily for 3 days. On day 4, they were transported back to the original site via trailer for 4 hours. On day 5, endoscopic examinations were performed on all horses to assess gastric mucosa status. RESULTS: Horses that were transported and housed off-site had a significantly higher incidence of hyperkeratosis and reddening of the gastric mucosa than control horses. Two control horses and 7 transported horses developed gastric ulcers by day 5. Ulcer scores of transported horses increased significantly from day -1, whereas ulcer scores in control horses did not change significantly from day -1. CONCLUSIONS AND CLINICAL RELEVANCE: Activities that are typical in recreational use of horses were ulcerogenic, and ulcers in the gastric squamous mucosa can develop under these conditions within 6 days.